![Robert M. Murphy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert M. Murphy
Nessuna posizione attualmente
Storia della carriera di Robert M. Murphy
Precedenti posizioni note di Robert M. Murphy
Società | Posizione | Inizio | Fine |
---|---|---|---|
LAB International, Inc.
![]() LAB International, Inc. Pharmaceuticals: MajorHealth Technology LAB International (LAB Pharma and LAB Research) is an integrated drug development company. LAB Pharma is focused on the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, and growth hormone deficiencies | Direttore/Membro del Consiglio | - | 13/07/2007 |
Corporate Officer/Principal | - | 13/07/2007 | |
Presidente | - | 13/07/2007 |
Statistiche
Distribuzione geografica
Canada | 2 |
Posizioni
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
President | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
LAB International, Inc.
![]() LAB International, Inc. Pharmaceuticals: MajorHealth Technology LAB International (LAB Pharma and LAB Research) is an integrated drug development company. LAB Pharma is focused on the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, and growth hormone deficiencies | Health Technology |
- Borsa valori
- Insiders
- Robert M. Murphy
- Esperienza